Butein and Its Role in Chronic Diseases
Authors:
- 25 September 2016
- book chapter
- Published by Springer Nature
- Vol. 928, 419-433
Abstract
Natural compounds isolated from various plant sources have been used for therapeutic purpose for centuries. These compounds have been routinely used for the management of various chronic ailments and have gained considerable attention because of their significant efficacy and comparatively low side effects. Butein, a chacolnoid compound that has been isolated from various medicinal plants has exhibited a wide range of beneficial pharmacological effects, such as anti-inflammatory, anticancer, antioxidant, and anti-angiogenic in diverse disease models. This article briefly summarizes the past published literature related to the therapeutic and protective effects of butein, as demonstrated in various models of human chronic diseases. Further analysis of its important cellular targets, toxicity, and pharmacokinetic profile may further significantly expand its therapeutic application.Keywords
This publication has 71 references indexed in Scilit:
- Butein suppresses cervical cancer growth through the PI3K/AKT/mTOR pathwayOncology Reports, 2015
- Suppressive effects of Indigofera suffruticosa Mill extracts on lipopolysaccharide-induced inflammatory responses in murine RAW 264.7 macrophagesFood and Chemical Toxicology, 2013
- Antirestenosis Effect of Butein in the Neointima Formation ProgressionJournal of Agricultural and Food Chemistry, 2012
- Neuroprotective and anti-inflammatory effects of flavonoids isolated from Rhus verniciflua in neuronal HT22 and microglial BV2 cell linesFood and Chemical Toxicology, 2012
- Generation of reactive oxygen species mediates butein-induced apoptosis in neuroblastoma cellsOncology Reports, 2012
- Flavonoid inhibitors as novel antimycobacterial agents targeting Rv0636, a putative dehydratase enzyme involved in Mycobacterium tuberculosis fatty acid synthase IIMicrobiology, 2007
- Butein, a more effective antioxidant than α-tocopherolJournal of Molecular Structure: THEOCHEM, 2006
- Inhibition of PI3K/Akt Signaling: An Emerging Paradigm for Targeted Cancer TherapyCurrent Medicinal Chemistry - Anti-Cancer Agents, 2005
- The Role of Natural Product Chemistry in Drug DiscoveryJournal of Natural Products, 2004
- Three New Flavonoids and Antiallergic, Anti-Inflammatory Constituents from the Heartwood ofDalbergia odoriferaPlanta Medica, 1998